SignatureFD
USNA icon

SignatureFD’s Usana Health Sciences USNA Stock Holding History

SignatureFD’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-4,749
Closed -$101K – 3669
2026
Q2 		$101K Buy
4,749
+4,311
+984% +$81K ﹤0.01% 1438
2026
Q1 		$7.65K Sell
438
-374
-46% -$7.42K ﹤0.01% 2624
2025
Q4 		$15.9K Sell
812
-18
-2% -$373 ﹤0.01% 2216
2025
Q3 		$22.9K Sell
830
-12
-1% -$369 ﹤0.01% 2051
2025
Q2 		$25.7K Buy
842
+97
+13% +$2.75K ﹤0.01% 1932
2025
Q1 		$20.1K Buy
745
+361
+94% +$11.4K ﹤0.01% 2058
2024
Q4 		$13.8K Buy
384
+291
+313% +$10.9K ﹤0.01% 2239
2024
Q3 		$3.53K Sell
93
-124
-57% -$5.1K ﹤0.01% 2676
2024
Q2 		$9.8K Sell
217
-296
-58% -$13.6K ﹤0.01% 2273
2024
Q1 		$24.9K Sell
513
-230
-31% -$11.3K ﹤0.01% 1886
2023
Q4 		$39.8K Sell
743
-364
-33% -$18.4K ﹤0.01% 1585
2023
Q3 		$64.9K Sell
1,107
-232
-17% -$14.5K ﹤0.01% 1264
2023
Q2 		$84.4K Sell
1,339
-85
-6% -$5.41K ﹤0.01% 1148
2023
Q1 		$89.6K Buy
1,424
+787
+124% +$47K ﹤0.01% 1095
2022
Q4 		$33.9K Buy
637
+242
+61% +$13.1K ﹤0.01% 1548
2022
Q3 		$22K Buy
395
+71
+22% +$4.69K ﹤0.01% 1698
2022
Q2 		$23K Buy
324
+194
+149% +$14.4K ﹤0.01% 1703
2022
Q1 		$10K Buy
130
+105
+420% +$9.47K ﹤0.01% 2176
2021
Q4 		$3K Buy
25
+2
+9% +$200 ﹤0.01% 2628
2021
Q3 		$2K Buy
23
+4
+21% +$385 ﹤0.01% 2715
2021
Q2 		$2K Buy
19
+5
+36% +$502 ﹤0.01% 2627
2021
Q1 		$1K Buy
14
+12
+600% +$1.09K ﹤0.01% 2692
2020
Q4 		$0 Sell
2
-24
-92% -$1.86K ﹤0.01% 2711
2020
Q3 		$2K Sell
26
-20
-43% -$1.6K ﹤0.01% 2287
2020
Q2 		$3K Buy
46
+26
+130% +$2.04K ﹤0.01% 2027
2020
Q1 		$1K Buy
+20
New +$1.39K ﹤0.01% 2213
2019
Q3 		– Sell
-28
Closed -$2K – 2208
2019
Q2 		$2K Buy
+28
New +$2.22K ﹤0.01% 1794

Other funds holding USNA

Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Royce & Associates
Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return

SignatureFD's USNA Position: Q3 2026 in Review

SignatureFD sold out of Usana Health Sciences (USNA) in Q3 2026, closing a stake of 4,749 shares — an estimated $101K sold.

SignatureFD first reported a position in USNA in Q2 2019 and held it in 27 quarters. The position peaked at $101K in Q2 2026. 57 funds tracked by Wall St. Rank hold USNA as of Q3 2026.

  • SignatureFD reported no remaining Usana Health Sciences position as of Q3 2026 after selling out during the quarter.
  • SignatureFD sold 4,749 Usana Health Sciences shares in Q3 2026, an estimated $101K.
  • SignatureFD first reported a position in Usana Health Sciences in Q2 2019 and held it in 27 quarters.
  • SignatureFD's Usana Health Sciences position peaked at $101K in Q2 2026.
  • 57 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.